Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bank of America

HCA Healthcare

Lowe's

Oracle

Dollar General

These six cheap dividend stocks are worth buying given that the company's earnings more than cover their dividend payments. The post 6 Cheap Dividend Stocks to Buy in July appeared first on InvestorPlace.

6 Cheap Dividend Stocks to Buy in July

Merck

Valero Energy

All three sport strong Zacks Ranks - a significant perk that instills confidence in these companies' share performances moving forward.

3 Large-Cap Stocks up More Than 20% Year-To-Date

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Cigna (CI) Could Beat Earnings Estimates Again

Cigna (CI) closes the deal to divest its life, accident and supplemental benefits businesses to Chubb. CI primarily intends to pursue share repurchases with proceeds received from the transaction.

Cigna (CI) Divests Units to Chubb for Net $5.1 Billion

Chubb

Cigna divests life, accident and supplemental benefits businesses in six Asia-Pacific markets to sharpen focus on its expanding health portfolio BLOOMFIELD, Conn. , July 1, 2022 /PRNewswire/ -- Cigna Corporation (NYSE: CI), a global health services company, today announced the completion of the company's previously announced divestiture of its life, accident and supplemental benefits businesses in six markets across Asia Pacific to Chubb (NYSE: CB) in an approximately $5.4 billion transaction.

Cigna Completes Transaction with Chubb

ZURICH , July 1, 2022 /PRNewswire/ -- Chubb Limited (NYSE: CB) today announced that it has completed its acquisition of the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna (NYSE: CI) in six Asia-Pacific markets. Chubb paid $5.36 billion for the operations, which include Cigna's accident and health (A&H) and life business in Korea, Taiwan, New Zealand, Thailand, Hong Kong and Indonesia.

Chubb Completes Acquisition of Cigna's Personal Accident, Supplemental Health and Life Insurance Business in Asia-Pacific

Booking Hlds

Discovery

Discovery Communications

Alphabet

Michael Burry, the hedge fund manager, best known for his bet against the housing market bubble in 2008, has started.

4 stocks ‘TheBig Short' M. Burry endorses despite expecting more pain in the markets

Cigna 360 Global Well-Being Survey of 11,922 people worldwide reveals expat stress has reached an all-time high, with almost all respondents feeling symptoms of burnout Lifestyle is now more important than finances for those planning to move overseas, a quarter plan to move to access better healthcare Top destination for existing expats to relocate to is Canada, with Australia and the U.S. tied second HONG KONG , June 23, 2022 /PRNewswire/ -- The vast majority of expats are burned out, stressed and reevaluating life and work priorities for more flexibility or to be closer to family and friends, according to a report based on the eighth edition of the Cigna 360 Well-Being Survey. The report released today, Burned Out Overseas – The State of Expat Life 2022 , found 90% of expats are stressed and 98% have experienced symptoms of burnout - likely driven by feeling unable to switch off from work.

Expat Burn Out Signals a 'Huge Challenge' for Employers

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has revised the outlooks to positive from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of “a” (Excellent) of the key U.S. life/health subsidiaries, health maintenance organizations and Europe-based insurance companies of Cigna Corporation (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI]. The outlook of the FSR is stable. Concurrently, AM Best has

AM Best Revises Issuer Credit Rating Outlook to Positive for Cigna Corporation and Most of Its Subsidiaries; Affirms Credit Ratings

Cigna (CI) intends to buy back at least $7 billion worth of its stocks this year alone.

Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements

Cigna Corp. CI, +0.57% announced Thursday that it will buy back $3.5 billion of its common stock through accelerated stock repurchase (ASR) agreements. That represents about 4.5% of the health insurer's market capitalization of $78.4 billion as of Wednesday's stock closing price of $247.10.

Cigna to buy back $3.5 billion of its stock through accelerated repurchases

BLOOMFIELD, Conn. , June 16, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) will repurchase $3.5 billion of common stock through accelerated stock repurchase agreements (the "ASR Agreements") with Mizuho Markets Americas LLC and Morgan Stanley & Co. LLC (the "Counterparties").

Cigna Announces $3.5 Billion Accelerated Stock Repurchase Agreements

Cigna does not get as much attention as other large healthcare companies but is growing at a rapid pace. The rising price of healthcare, increasing number of consumers with health insurance, and steady population growth will cause higher demand for the company's services.

Cigna: A Forgotten Gem

Cigna (CI) expects 2022 medical customers to grow by a minimum of 725,000, suggesting an upside from the prior projection.

Here's Why Investors Should Bet on Cigna (CI) Stock Now

Cigna (CI) could produce exceptional returns because of its solid growth attributes.

3 Reasons Growth Investors Will Love Cigna (CI)

This commentary first appeared on Forbes Great Speculations , where Schaeffer's Investment Research is a regular contributor.

Why Cigna Stock's Rally Could Have Legs

Cigna has traded at a relatively modest valuation in recent years, but the recent flight to safety woke up the bulls. The business continues to deliver very reliable results, but for an insurance company, Cigna is not particularly profitable.

Cigna: No Reason To Expect Much Upside

Cigna is one of America's largest healthcare companies, thanks to strong organic growth and major acquisitions. The company has turned into a cash machine, generating strong, double-digit free cash flow yields used to aggressively buy back shares and grow its dividend.

What To Make Of Cigna's Dividends

In this article, we'll take a look at healthcare company Cigna. The company is a giant in the field of healthcare insurance. With almost 74,000 employees and revenues over $174 billion, this business is one of the largest on earth in terms of healthcare insurance and other services.

Cigna: A Giant In The Industry Is A 'Buy'

Amphenol

Ball Corp

Domino's Pizza

Home Depot

Mastercard

Starbucks

Charles Schwab

SS&C Technologies Hlds

Skyworks Solutions

Tractor Supply

Visa

I present my top 15 high-growth dividend stocks to consider during the month of June. The watchlist performed well in May but is still down 9.59% this year.

My Top 15 High Growth Dividend Stocks For June 2022

Bausch Health Companies Inc

Fiserv

McKesson

US Foods Holding

Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed in a regulatory filing that its top five trades during the first quarter included boosts to its holdings of Fiserv Inc. ( FISV , Financial), Cigna Corp. ( CI , Financial) and US Foods Holding Corp. ( USFD , Financial) and reductions to its positions in McKesson Corp. ( MCK , Financial) and Bausch Health Companies Inc. ( BHC , Financial).

Top 5 Trades of Larry Robbins' Firm in the 1st Quarter

ConocoPhillips

UnitedHealth Group

Exxon Mobil

We have narrowed our search to five U.S. corporate behemoths (market capital > $50 billion). These are: MMM, CI, UNH, XOM and COP.

Volatility Reigns Supreme on Wall Street: Top 5 Picks for June

Teck Resources

United States Oil Fund LP

When we began working on this post the idea was to write up the three most upgraded stocks so far in Q2. Things changed, however, when we discovered that the three most upgraded stocks in Q2 are all energy stocks.

These Are the Three (3) Most Upgraded Stocks For Q2

BB Seguridade Participacoes SA

CI vs. BBSEY: Which Stock Is the Better Value Option?

CI vs. BBSEY: Which Stock Should Value Investors Buy Now?

Crocs

CrowdStrike

Ford Motor Company

Micron Technology

Nokia

The most undervalued stocks to buy right now are trading at attractive valuations and poised for big gains in the future. The post The 7 Most Undervalued Stocks to Buy for June 2022 appeared first on InvestorPlace.

News for Cigna Stock (CI)